Stanford School of Medicine

A proposed cancer center in Redwood City would combine care and research to advance treatments for a growing patient population.

In a small pilot study, a Stanford Medicine-developed tool showed promise by decreasing physician burnout while maintaining safety.

Stanford Medicine’s new proton therapy facility is ready for patients. On June 4 a child with a rare brain tumor became the first to receive treatment.

Research shows that obexelimab halves relapse risk in patients with IgG4-related disease, a chronic immune condition often misdiagnosed as cancer.

The discovery that hormonal triggers cause “ruptoblast” cells in flatworms to detonate and destroy surrounding cells within minutes could inspire new ideas in medical science.

Two existing drugs improve mucus clearance in animal models of cystic fibrosis, indicating a potential pathway to reduce chronic lung infections in humans.

Many taking GLP-1 medications lose muscle as they shed fat. A study in mice suggests an existing drug could aid in muscle regeneration without affecting weight loss.

Stanford Medicine experts explain why it’s harder than ever to focus – and what we can do to block out distractions that often cloud our attention and memory.

Stanford Medicine pediatrician Anisha Patel shares five things to know about the new federal guidelines on nutrition.

Researchers have developed a lab model of the human uterus to observe embryo implantation for the first time, paving the way for improved IVF success rates and enhanced fertility treatments.